-
2024-511070-68-01
5
2024-09-24
Ampullary adenocarcinoma
-
2022-502408-57-00
5
2024-09-04
Novo metastatic hormone-sensitive prostate cancer (mHSPC) patients hav
-
2023-508435-31-00
1
2024-08-09
Advanced Solid Tumors, Advanced Breast Cancer
-
2023-508005-24-00
5
2024-08-01
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
2023-508260-30-01
5
2024-07-30
Patients with poor prognostic OVARian cancers based on the tumor prima
-
2024-514083-31-00
4
2024-07-26
squamous cell anal carcinoma
-
2023-504962-52-00
5
2024-07-10
Triple negative breast cancer.
-
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
-
2023-503886-44-00
5
2024-06-10
Patients with a histological diagnosis of p53abn HREC, treated with cu
-
2023-506282-66-00
5
2024-05-27
Women with ER+ HER2- metastatic breast cancer who progressed on first
-
2023-506753-38-00
4
2024-04-16
metastatic gastric adenocarcinoma
-
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-506885-30-00
5
2024-03-26
Adult patients with intermediate low or mid rectal adenocarcinoma to b
-
2023-505925-15-00
7
2024-03-21
Patients with HER2-positive (HER2-pos) (cohort 1) or HER2-low defined
-
2023-504323-25-01
5
2024-03-19
breast cancer
-
2023-505898-32-00
9
2024-02-28
Metastasic Castration-Resistant Prostate Cancer (mCRPC)
-
2022-502351-60-00
4
2024-02-22
Patients having a HER2-amplified metastatic breast cancer with evoluti
-
2023-504807-94-00
7
2023-12-26
Breast Cancer; Advanced solid tumors including but not limited to gyne
-
2022-501316-34-00
4
2023-11-27
Patient cured from a primary cancer and at risk of 2nd cancer
-
2023-504618-31-00
5
2023-10-20
Chemotherapy induced peripheral neuropathy (CIPN)
-
2022-502426-41-00
5
2023-10-17
Thromboprophylaxis in good and intermediate prognosis advanced germ ce
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2024-512999-35-00
4
2023-06-23
Patients with HER 2 negative locally advanced, recurrent or metastatic